Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

Click for more information

3.93%

$19.31 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-9

First 9 Last

Share
Profile

Follow
Potstock88

421 Posts.

133

13/12/21

16:42

Post #: 58261771
Share

Originally posted by hottod: ↑

I think that MST Access is more likely to be right on this, as it was engaged by Neuren. MST states that the ACAD agreement includes “payments over CY22/23 on FDA approval and market entry”.

Also, in the results conference last week, Jon Pilcher talked about expected payments based on the assumption that the FDA approves trofinetide and that the product is launched.

It’s possible that NDA filing will trigger a payment, but it looks likely that the first payment will be due on FDA approval which, if all goes well, could be next November or December.

Expand

Hi hottod. I refer you to the webcast where JP is speaking. He makes it quite clear that the first milestone payment will be in early 2022.

NEU Price at posting: $4.01 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 939 more messages in this thread...

First 9 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $19.31		Change -0.790(3.93%)		Mkt cap ! $2.465B

Open	High	Low	Value	Volume
$19.86	$19.99	$17.97	$22.67M	1.196M

Buyers (Bids)

No.	Vol.	Price($)
1	2222	$19.19

Sellers (Offers)

Price($)	Vol.	No.
$19.31	8162	3

View Market Depth

No.	Vol.	Price($)
1	2222	19.190
2	1198	19.080
1	50	19.060
2	3459	19.040
1	1935	19.020

Price($)	Vol.	No.
19.330	2587	1
19.340	530	1
19.370	2587	2
19.400	2680	1
19.420	2587	1

Last trade - 16.10pm 09/05/2024 (20 minute delay)


Last $19.25			Change -0.790 ( 4.18 %)
Open	High		Low	Volume
$19.88	$19.88		$17.97	249066
Last updated 15.59pm 09/05/2024 ?

NEU (ASX) Chart